Home › Occupations › Molecular and Cellular Biologists › Raleigh, NC
Molecular and Cellular Biologists in Raleigh, NC: H-1B salaries
36 labor condition applications for this occupation with a work site in Raleigh, NC. Median offered base salary $65,000; middle half $59,736–$75,000.
By wage level
| Wage level | Median salary |
|---|---|
| Level I (entry) | $61,800 |
| Level II (qualified) | $65,000 |
| Level IV (fully competent) | $150,267 |
The Department of Labor sets four prevailing wage levels for each occupation and area, from Level I (entry) to Level IV (fully competent). The employer picks the level that matches the job's requirements.
Employers
| Employer | LCAs | Median salary |
|---|---|---|
| North Carolina State University | 22 | $61,800 |
| The Pennsylvania State University | 3 | $59,472 |
| ASRT, Inc. | 2 | $105,000 |
| University of Michigan | 1 | $73,500 |
| Symmetry BioSciences Inc. | 1 | $53,200 |
| DermBiont, Inc. | 1 | $110,000 |
| SunTechPros, Inc. | 1 | $80,000 |
| University of Colorado Denver | 1 | $60,237 |
| PPD Development, L.P. | 1 | $127,060 |
| Elysia Creative Biology, Inc. | 1 | $75,000 |
| Bristol-Myers Squibb Company | 1 | $150,267 |
| Duke University | 1 | $90,263 |
Job titles
- Postdoctoral Research Scholar12
- Assistant Research Professor3
- Research Scholar3
- Research Associate3
- Research Specialist2
- Research Scientist2
- Bioinformatician II2
- Social/Clinical Research Specialist1
- Bioinformatician/Computational Biologist-Intermed1
- Formulation Scientist1
- Bioinformatic Statistical Scientist1
- Research Services Sr. Professional / Bioinformatics Analyst1
- Senior Programmer Analyst (Bioinformatics)1
- Genetic Engineer1
- Senior Manager, Clinical Data Management1
H-1B sponsors in Raleigh, NC →
Salaries are the lower end of the wage offered on each application, converted to a yearly amount; statistics use certified full-time applications only. An LCA is not a visa approval and one LCA can cover several positions. Source: U.S. Department of Labor, OFLC LCA Disclosure Data, fiscal years 2023–2026 (latest decision Jun 30, 2026).